Source: Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
John P. Scott, Yinduo Ji, Mathur Kannan, Mark E. Wylam. Inhaled granulocyte–macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis. Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017

Member's Comments

No comment yet.

Related content which might interest you: Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis Source: Eur Respir J 2006; 27: 585-593 Year: 2006 Plasmapheresis for treatment of pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1220-1222 Year: 2009 Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J 2016; 47: 990-993 Year: 2016 Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP) Source: Eur Respir J 2001; 18: Suppl. 33, 221s Year: 2001 Alveolar lipoproteinosis syndromes Source: Eur Respir Mon 2011; 54: 171-186 Year: 2011 Rituximab therapy in autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1503-1506 Year: 2009 Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation Source: Eur Respir J 2013; 41: 433-442 Year: 2013 Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD Source: Eur Respir J 2008; 32: 25-34 Year: 2008 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013 Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis Source: Short video statement 2020 Year: 2020 A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018 Increased vascular endothelial growth factor in acute eosinophilic pneumonia Source: Eur Respir J 2003; 21: 774-778 Year: 2003 Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020 Year: 2020 Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017 Year: 2018 Successful treatment by GMCSF of pulmonary alveolar proteinosis relapsing after a first GMCSF course Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit Source: ERJ Open Res, 6 (1) 00259-2019; 10.1183/23120541.00259-2019 Year: 2020 Granulocyte colony-stimulating factor enhances the anticancer effects of cisplatin against lung cancer by promoting angiogenesis Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021